Oncologic outcomes following radical prostatectomy with intraoperative cell salvage

Michael A. Gorin, Ahmed Eldefrawy, Murugesan Manoharan, Mark S. Soloway

Research output: Contribution to journalArticle

16 Scopus citations

Abstract

Purpose: To evaluate oncologic outcomes following the use of intraoperative cell salvage (IOCS) as a blood loss management strategy during open radical prostatectomy (RP). Methods: We retrospectively reviewed all open retropubic RP cases performed by a single surgeon. Patients were identified who received IOCS blood and evaluated for an increased risk of biochemical recurrence (BCR) and overall mortality. Results: The study cohort consisted of 1,862 men, 395 (21.2%) of whom received IOCS blood. At a median follow-up of 47.0 months, men who received IOCS blood were not at an increased risk of BCR (P = 0.323) or all-cause mortality (P = 0.892). IOCS use did not confer an increased risk of BCR within any D'Amico preoperative risk category (low risk, P = 0.592; intermediate risk, P = 0.107; and high risk, P = 0.697). Conclusions: IOCS is safe for the management of blood loss during RP. At long-term follow-up, IOCS use was not associated with an increased risk of BCR or death. While it remains preferable to avoid any form of blood transfusion, we advocate for the use of IOCS in place of allogeneic blood. These conclusions are drawn from our study of the largest and longest followed cohort patients who received IOCS blood during RP.

Original languageEnglish (US)
Pages (from-to)379-383
Number of pages5
JournalWorld journal of urology
Volume30
Issue number3
DOIs
StatePublished - Jun 1 2012

Keywords

  • Biochemical recurrence
  • Blood transfusion
  • Intraoperative cell salvage
  • Prostate cancer
  • Radical prostatectomy

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Oncologic outcomes following radical prostatectomy with intraoperative cell salvage'. Together they form a unique fingerprint.

  • Cite this